[india-drug] COX-2 in New England Journal of Medicine

["Leela McCullough" <leela@healthnet.org>]

Dear colleagues,

Early release from the New England Journal of Medicine 
(posted February 15, 2005)
 
Original Articles 
-------------------------
 
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention <http://content.nejm.org/cgi/reprint/NEJMoa050405v1.pdf>
 
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
<http://content.nejm.org/cgi/reprint/NEJMoa050330v1.pdf>

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
<http://content.nejm.org/cgi/reprint/NEJMoa050493v1.pdf>
 
Editorials
--------------
 
COX-2 Inhibitors -- A Lesson in Unexpected Problems
<http://content.nejm.org/cgi/reprint/NEJMe058038v1.pdf>

COX-2 Inhibitors -- Lessons in Drug Safety
<http://content.nejm.org/cgi/reprint/NEJMe058042v1.pdf>

Kind regards,
Leela McCullough
SATELLIFE
Director of Information Services